Abiopharma

🔍 Zhu Xiaotong (Executive)

Company: Tesla, Inc. (TSLA)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 20,000 shares of Common Stock at $20.57 per share (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 20,000.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 47,599.75 | Footnotes: F1
• Sold 20,000 shares of Non-Qualified Stock Option (right to buy) at $20.57 per share (Derivative)
  Date: 2026-03-31 | Code: M | Expires: 2028-08-20 | equity_swap_involved: 0 | shares_owned_after: 260,650.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The shares are held in Magical Blake Global Limited, a BVI entity, for which the Reporting Person is the sole beneficial owner.
• F2: Represents option awards granted with respect to 375,000 total shares initially, which vest as follows: (a) with respect to 150,000 shares subject to the options, 1/48th of such shares became vested and exercisable upon the Issuer's achievement of certain performance objectives set forth in the option agreements, and 1/48th of the shares become vested and exercisable on each monthly anniversary thereafter, and (b) with respect to 225,000 shares subject to the options, 1/60th of such shares became vested and exercisable on August 20, 2018, and 1/60th of the shares become vested and exercisable each month thereafter.